- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07528573
HIV Prevention and Care Engagement in Nepal
April 7, 2026 updated by: Public Health Foundation Enterprises, Inc.
Sweekar - Multi-level Intersectional Stigma Reduction Intervention to Increase HIV Testing and Care Engagement in Nepal
This intervention focuses on increasing HIV testing, HIV medication adherence and reducing intersectional stigma.
Our Sweekar intervention will implement 5 months of group-based activities to address the social stigma and HIV prevention and care needs.
Study Overview
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kathmandu, Nepal
- BDS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- aged 18 years old or older
- identify as transgender, hijra, Meti, third gender or anything other than a gender typically associated with a male assigned sex at birth
- live in the Terai highway district Madesh Province
- Maithili- or Nepali-speaking
- Willing to be part of the study for 6 months
- Willing to travel, if needed, to participate in group sessions
For those who test HIV negative:
- Willing to self-test
- Have or willing to have a mobile phone
- Not HIV tested within the last 3 months
For those who test HIV positive:
(a) screen positive for HIV treatment non-adherence by self-report
Exclusion Criteria:
- Cannot or will not consent to the research,
- Female sex assigned at birth,
- Self-identify as a man
- Do not speak Maithli or Nepali
- Age under 18 -
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group-based intervention
Group-based activities and HIV self-testing to address social stigma and HIV prevention and care needs
|
The HIV prevention components focus on HIV education and use of HIV self-testing kits to increase frequency of HIV testing.
The HIV care component is information and linkage to HIV treatment information and adherence support.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HIV testing Self-testing kits
Time Frame: At baseline and at 3 months
|
Number of HIV self tests kits used at home or at a hospital or clinic
|
At baseline and at 3 months
|
|
HIV testing frequency
Time Frame: Baseline, 3 months and 6 months
|
HIV testing; Number of times received HIV testing using clinic or resources that is not HIV self-testing kits
|
Baseline, 3 months and 6 months
|
|
HIV treatment engagement
Time Frame: At baseline, 3 months and 6 months
|
Self-reported Wilson's Medication Scale to assess adherence patterns.
|
At baseline, 3 months and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 27, 2024
Primary Completion (Actual)
May 31, 2025
Study Completion (Actual)
May 31, 2025
Study Registration Dates
First Submitted
October 27, 2025
First Submitted That Met QC Criteria
April 7, 2026
First Posted (Actual)
April 14, 2026
Study Record Updates
Last Update Posted (Actual)
April 14, 2026
Last Update Submitted That Met QC Criteria
April 7, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 4632024
- R01TW012397 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Upon request, data may be made available
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Federal University of São PauloGilead SciencesCompleted
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
Clinical Trials on Sweekar intervention
-
Biolux Research Holdings, Inc.TerminatedOrthodontic Tooth MovementCanada
-
Nottingham Trent UniversityUnknownOverweight and ObesityUnited Kingdom
-
University of Southern DenmarkTrygFonden, DenmarkUnknownObesity | Overweight | Metabolic Syndrome | ChildrenDenmark
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedColorectal Carcinoma | Healthy Subject | Health Status UnknownUnited States
-
University of FloridaCompletedSensitivityUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8United States
-
Vanderbilt UniversityCompletedMath Learning Disability | Reading Learning DisabilityUnited States
-
Universidad de ExtremaduraDiputación Provincial de BadajozRecruitingHealth Education | Gamification in Health EducationSpain